{"content":"<li class=\"n-box-item date-title\" data-end=\"1553313599\" data-start=\"1553227200\" data-txt=\"Monday, December 23, 2019\">Friday, March 22, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3445220\" data-ts=\"1553290946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445220-doc-nbr-habt-and-rgnx-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOC, NBR, HABT and RGNX among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a> <font color=\"green\">+4.8%</font>. <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/RMTI' title='Rockwell Medical, Inc.'>RMTI</a> <font color=\"green\">+3.4%</font>. <a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a> <font color=\"green\">+2.4%</font>. <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color=\"green\">+2.3%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants, Inc.'>HABT</a> <font color=\"red\">-2.8%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO Inc.'>RGNX</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/CPLG' title='CorePoint Lodging Inc.'>CPLG</a> <font color=\"red\">-1.9%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color=\"red\">-1.5%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color=\"red\">-1.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445220\" data-linked=\"DOC, NBR, HABT and RGNX among notable after hour movers\" data-tweet=\"$DOC $SENS $RMTI - DOC, NBR, HABT and RGNX among notable after hour movers https://seekingalpha.com/news/3445220-doc-nbr-habt-and-rgnx-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445220-doc-nbr-habt-and-rgnx-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445191\" data-ts=\"1553284738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445191-analysts-keep-faith-in-nike-despite-cool-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts keep the faith in Nike despite cool guidance</a></h4><ul><li>Nike (<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a> <font color='red'>-6.5%</font>) slumps to six-week lows after beating <a href=\"https://seekingalpha.com/news/3444931-nike-profit-beats-amid-broad-revenue-margin-gains\" target=\"_blank\">FQ3 earnings</a> expectations but saying foreign exchange would knock about six percentage points off Q4 revenues, \u201cwhich would result in low-single digit reported revenue growth,\u201d CFO Andrew Campion said in the company's <a href=\"https://seekingalpha.com/article/4250413-nike-inc-nke-ceo-mark-parker-q3-2019-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>.</li><li>But analysts such as Susquehanna's Sam Poser are <a href=\"https://www.marketwatch.com/story/nike-shares-tumble-after-conservative-outlook-but-analysts-say-dont-be-fooled-2019-03-22\" target=\"_blank\">still bullish</a> thanks to the company's strong fundamentals.</li><li>\u201c[D]o not be fooled... underlying momentum remains incredibly strong,\u201d Poser says. \u201cIncreasing digital prowess, a robust product pipeline, and exceptionally clean inventory will continue to drive healthy FX neutral revenue and margin growth across categories and geographies for the foreseeable future.\u201d</li><li>\u201cPaired with FY4Q guidance that disappointed relative to published estimates and elevated expectations, we are not surprised by pressure on shares,\u201d according to analysts at Cowen, who maintain their Buy rating and $96 price target. \u201cDespite the setback, we remain confident in fundamental momentum and long-term value creation opportunity.\u201d</li></ul><div class=\"tiny-share-widget\" data-id=\"3445191\" data-linked=\"Analysts keep the faith in Nike despite cool guidance\" data-tweet=\"$NKE - Analysts keep the faith in Nike despite cool guidance https://seekingalpha.com/news/3445191-analysts-keep-faith-in-nike-despite-cool-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3445191-analysts-keep-faith-in-nike-despite-cool-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445184\" data-ts=\"1553283668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPH\" target=\"_blank\">REPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445184-fda-rejects-recro-pharmas-iv-meloxicam-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Recro Pharma&#39;s IV meloxicam again</a></h4><ul><li>Recro Pharma (<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a> <font color=\"green\">+1.2%</font>) is set for a significant down move after receiving a <a href=\"https://seekingalpha.com/pr/17453002-recro-pharma-receives-complete-response-letter-fda-intravenous-meloxicam\" target=\"_blank\">Complete Response Letter</a> &#40;CRL&#41; from the FDA regarding its marketing application for IV meloxicam, its second.</li><li>The CRL stated that the delayed onset of the drug fails to meet prescriber expectations for intravenous &#40;IV&#41; drugs. It also cited regulatory concerns about the role of IV meloxicam as monotherapy in acute pain and how it would meet patients and prescriber needs in that setting.</li><li>It received the <a href=\"https://seekingalpha.com/news/3359222-fda-rejects-recro-pharmas-marketing-application-iv-meloxicam\" target=\"_blank\">first CRL</a> in May 2018.</li><li>Trading is currently suspended.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445184\" data-linked=\"FDA rejects Recro Pharma&#39;s IV meloxicam again\" data-tweet=\"$REPH - FDA rejects Recro Pharma&#39;s IV meloxicam again https://seekingalpha.com/news/3445184-fda-rejects-recro-pharmas-iv-meloxicam-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3445184-fda-rejects-recro-pharmas-iv-meloxicam-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445181\" data-ts=\"1553283225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445181-roth-meet-tremendous-room-for-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roth: Meet has &quot;tremendous&quot; room for growth</a></h4><ul><li>Roth Capital Partners says the Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) has \"tremendous\" room to grow its live-video service in the \"early stages\" of its reach.</li><li>Rating maintained at Buy with an $8 price target.</li><li>MEET shares are <font color=\"green\">up 0.8%</font> to $5.67.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445181\" data-linked=\"Roth: Meet has &quot;tremendous&quot; room for growth\" data-tweet=\"$MEET - Roth: Meet has &quot;tremendous&quot; room for growth https://seekingalpha.com/news/3445181-roth-meet-tremendous-room-for-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3445181-roth-meet-tremendous-room-for-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445180\" data-ts=\"1553282633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445180-tiffany-rebounds-after-forecasting-slight-growth-for-year-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiffany rebounds after forecasting slight growth for year ahead</a></h4><ul><li>Tiffany (<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a> <font color='green'>+3.2%</font>) climbs as much as 3.8% after forecasting a <a href=\"https://www.reuters.com/article/us-tiffany-results/tiffany-sticks-to-2019-targets-helped-by-e-commerce-shares-rebound-idUSKCN1R3184\" target=\"_blank\">resumption of earnings growth</a> in H2, helped by a healthy e-commerce business, a forecast that allowed investors to look past <a href=\"https://seekingalpha.com/news/3445018-tiffany-4-percent-mixed-q4-results\" target=\"_blank\">slightly disappointing Q4 sales</a>.</li><li>\"We expect a <a href=\"https://www.bloomberg.com/\" target=\"_blank\">rebound to double-digit EPS growth</a> on mid-single digit revenue growth over the long term,\" says Loop Capital's Laura Champine, who raises TIF\u2019s price target to $105 from $100. \"Though Tiffany\u2019s sales are under pressure in early 2019 on macroeconomic pressures, we expect an improving pace of growth as we move through the year.\"</li><li>TIF said its e-commerce business grew roughly 2x the rate of its overall business; later this year, it plans to launch an e-commerce enabled website in China to cater to the fast-growing market.</li><li>CEO Alessandro Bogliolo says he expects the company\u2019s percentage of total sales online, currently at 7%, to \"reach 10%, maybe even 15% one day,\" adding that \"I don\u2019t see that as a cannibalization of brick-and-mortar.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3445180\" data-linked=\"Tiffany rebounds after forecasting slight growth for year ahead\" data-tweet=\"$TIF - Tiffany rebounds after forecasting slight growth for year ahead https://seekingalpha.com/news/3445180-tiffany-rebounds-after-forecasting-slight-growth-for-year-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3445180-tiffany-rebounds-after-forecasting-slight-growth-for-year-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445178\" data-ts=\"1553282069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVTL\" target=\"_blank\">PVTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445178-wedbush-sees-massive-tailwinds-for-pivotal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush sees &quot;massive tailwinds&quot; for Pivotal</a></h4><ul><li>Wedbush analyst Daniel Ives says Pivotal Software (NYSE:<a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software, Inc.'>PVTL</a>) has \"massive tailwinds\" as businesses continue the shift towards cloud-based software systems. He sees the volatility after the <a href=\"https://seekingalpha.com/news/3443035-pivotal-drops-q4-revenue-miss-mixed-guide\" target=\"_blank\">earnings prin</a>t earlier this month as a good buying opportunity.</li><li>Ives says PVTL is on \"a clear path to profitability over the next few years, which many investors are overlooking.\"</li><li>Rating at Outperform with a $26 PT.</li><li>Pivotal Software shares are <font color=\"red\">down 3.5%</font> to $20.66.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445178\" data-linked=\"Wedbush sees &quot;massive tailwinds&quot; for Pivotal\" data-tweet=\"$PVTL - Wedbush sees &quot;massive tailwinds&quot; for Pivotal https://seekingalpha.com/news/3445178-wedbush-sees-massive-tailwinds-for-pivotal?source=tweet\" data-url=\"https://seekingalpha.com/news/3445178-wedbush-sees-massive-tailwinds-for-pivotal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445177\" data-ts=\"1553281725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445177-lexicon-down-29-on-fda-rejection-of-sotagliflozin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon down 29% on FDA rejection of sotagliflozin</a></h4><ul><li>Lexicon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"red\">-29.1%</font>) slumps on almost 50% higher volume in response to licensor Sanofi (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color=\"red\">-2.6%</font>) receiving a <a href=\"https://seekingalpha.com/pr/17452954-fda-issues-complete-response-letter-zynquista-sotagliflozin\" target=\"_blank\">Complete Response Letter</a> &#40;CRL&#41; from the FDA regarding its marketing application for Zynquista (sotagliflozin) as an adjunct to insulin to improve glycemic control in adults with type 1 diabetes.</li><li>About two months ago, an FDA advisory group rendered a <a href=\"https://seekingalpha.com/news/3424048-ad-com-splits-vote-sanofi-lexicons-sotagliflozin\" target=\"_blank\">split vote</a> of 8 - 8 on approval.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445177\" data-linked=\"Lexicon down 29% on FDA rejection of sotagliflozin\" data-tweet=\"$LXRX $SNY - Lexicon down 29% on FDA rejection of sotagliflozin https://seekingalpha.com/news/3445177-lexicon-down-29-on-fda-rejection-of-sotagliflozin?source=tweet\" data-url=\"https://seekingalpha.com/news/3445177-lexicon-down-29-on-fda-rejection-of-sotagliflozin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445172\" data-ts=\"1553281298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445172-microcaps-mostly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among tech movers</a></h4><ul><li><strong>Gainers: </strong>Intellicheck (NYSEMKT:<a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck, Inc.'>IDN</a>) <font color=\"green\">+14%</font>. CounterPath Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a>) <font color=\"green\">+7%</font>. Lantronix (NASDAQ:<a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a>) <font color=\"green\">+6%</font>.</li> <li><strong>Losers: </strong>Gridsum Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding Inc.'>GSUM</a>) <font color=\"red\">-13%</font>. JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"red\">-13%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-13%</font>. ACM Research (NASDAQ:<a href='https://seekingalpha.com/symbol/ACMR' title='ACM Research, Inc.'>ACMR</a>) <font color=\"red\">-11%</font>. Zuora (NYSE:<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445172\" data-linked=\"Microcaps mostly among tech movers\" data-tweet=\"$IDN $CPAH $LTRX - Microcaps mostly among tech movers https://seekingalpha.com/news/3445172-microcaps-mostly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445172-microcaps-mostly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445171\" data-ts=\"1553281293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445171-natura-confirms-avon-talks-avpplus-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natura confirms Avon talks, AVP +12%</a></h4><ul><li>Natura confirms talks with Avon (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) about a potential transaction, according to Bloomberg headlines.</li><li>Avon shares are <font color=\"green\">up 12%</font> to $3.11.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445027-avon-plus-6_8-percent-sale-talks-report\" target=\"_blank\">Avon +6.8% on sale talks report</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445171\" data-linked=\"Natura confirms Avon talks, AVP +12%\" data-tweet=\"$AVP - Natura confirms Avon talks, AVP +12% https://seekingalpha.com/news/3445171-natura-confirms-avon-talks-avpplus-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3445171-natura-confirms-avon-talks-avpplus-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445165\" data-ts=\"1553279857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEUGF\" target=\"_blank\">PEUGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445165-fiat-chrysler-rebuffed-peugeot-merger-pitch-earlier-this-year-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat Chrysler rebuffed Peugeot merger pitch earlier this year - WSJ</a></h4><ul><li>Peugeot (<a href='https://seekingalpha.com/symbol/PEUGF' title='Peugeot S.A.'>OTCPK:PEUGF</a> <font color='green'>+3%</font>) approached Fiat Chrysler (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles N.V.'>FCAU</a> <font color='red'>-2.8%</font>) earlier this year about <a href=\"https://www.wsj.com/articles/peugeot-after-digesting-gms-europe-business-set-sights-on-fiat-chrysler-11553277192\" target=\"_blank\">combining the two automakers</a>, but FCAU rebuffed the pitch, as it had previous approaches by the French firm, <em>WSJ</em> reports.</li><li>FCAU has said it is open to a big deal with another automaker if it fits the company\u2019s objectives but its controlling family, the Agnellis of Italy, opposes any deal that would include accepting a large proportion of Peugeot stock, according to the report.</li><li>Peugeot is still digesting its acquisition of General Motors' European business.</li><li><a href=\"https://seekingalpha.com/news/3444044-fiat-peugeot-higher-m-buzz\" target=\"_blank\">Earlier</a>: Fiat and Peugeot higher on M&amp;A buzz (Mar. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445165\" data-linked=\"Fiat Chrysler rebuffed Peugeot merger pitch earlier this year - WSJ\" data-tweet=\"$PEUGF $FCAU $PUGOY - Fiat Chrysler rebuffed Peugeot merger pitch earlier this year - WSJ https://seekingalpha.com/news/3445165-fiat-chrysler-rebuffed-peugeot-merger-pitch-earlier-this-year-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3445165-fiat-chrysler-rebuffed-peugeot-merger-pitch-earlier-this-year-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445163\" data-ts=\"1553279265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445163-newmont-investor-vaneck-backs-paulsons-concerns-goldcorp-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmont investor VanEck backs Paulson&#39;s concerns about Goldcorp deal</a></h4><ul><li>VanEck joins Paulson &amp; Co. in urging Newmont Mining (<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation'>NEM</a> <font color='green'>+0.7%</font>) to <a href=\"https://www.wsj.com/articles/investor-vaneck-urges-newmont-to-renegotiate-merger-deal-11553277350\" target=\"_blank\">renegotiate its proposed $10B merger</a> with Goldcorp (<a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='red'>-3.7%</font>), arguing the deal transfers away significant gains from the recently announced Nevada joint venture with Barrick Gold (<a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='green'>+2%</font>).</li><li>It's unfair that Goldcorp shareholders should benefit from the JV between Newmont and Barrick, given the agreement was negotiated after the Goldcorp-Newmont terms were set, says VanEck portfolio manager Joe Foster; activist investor Paulson <a href=\"https://seekingalpha.com/news/3444952-paulson-says-newmont-minings-merger-deal-goldcorp\" target=\"_blank\">expressed similar concerns yesterday</a>.</li><li>Foster also cites the \u201coutrageous payouts\u201d that would be given to Goldcorp executives after the merger.</li><li>VanEck owns nearly 6% of Newmont, spread across different funds.</li><li>\u201cPaulson\u2019s analysis might be aggressive, but I think directionally they have the right idea,\u201d <a href=\"https://finance.yahoo.com/news/vaneck-shares-paulson-apos-concerns-163644150.html\" target=\"_blank\">Foster tells Bloomberg</a>. \u201cI don\u2019t think shareholders should support the lavish lifestyles of the Goldcorp executives for one thing. And secondly, Goldcorp shareholders are not entitled to the JV synergies because it was not part of the deal.\u201d</li></ul><div class=\"tiny-share-widget\" data-id=\"3445163\" data-linked=\"Newmont investor VanEck backs Paulson&#39;s concerns about Goldcorp deal\" data-tweet=\"$NEM $GG $GOLD - Newmont investor VanEck backs Paulson&#39;s concerns about Goldcorp deal https://seekingalpha.com/news/3445163-newmont-investor-vaneck-backs-paulsons-concerns-goldcorp-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3445163-newmont-investor-vaneck-backs-paulsons-concerns-goldcorp-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445162\" data-ts=\"1553278848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445162-shopifyminus-3-on-mailchimp-breakup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify -3% on Mailchimp breakup</a></h4><ul><li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) and Mailchimp have parted ways with Shopify <a href=\"https://community.shopify.com/c/Shopify-Apps/Here-s-why-Mailchimp-is-no-longer-in-the-Shopify-App-Store/td-p/493593?utm_source=social&amp;utm_medium=twitter&amp;utm_campaign=guru%2Bask\" target=\"_blank\">saying</a> it removed Mailchimp's app on merchant experience concerns.</li><li>Mailchimp <a href=\"https://mailchimp.com/shopify-statement/\" target=\"_blank\">says</a> it asked Shopify to remove its integration from the marketplace, saying the new data terms \"jeopardize\" user privacy and required handing over data acquired outside Shopify.</li><li>Shopify shares are <font color=\"red\">down 2.8%</font> to $199.35.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445162\" data-linked=\"Shopify -3% on Mailchimp breakup\" data-tweet=\"$SHOP - Shopify -3% on Mailchimp breakup https://seekingalpha.com/news/3445162-shopifyminus-3-on-mailchimp-breakup?source=tweet\" data-url=\"https://seekingalpha.com/news/3445162-shopifyminus-3-on-mailchimp-breakup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445158\" data-ts=\"1553277882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445158-amyris-and-key-energy-services-among-energy-materials-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris and Key Energy Services among Energy/Materials losers</a></h4><ul><li><b>Gainers: </b>Barnwell Industries, Inc. (NYSEMKT:<a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc.'>BRN</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-15%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-14%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services Corp.'>PES</a>) <font color=\"red\">-11%</font>. Forum Energy Technologies (NYSE:<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies, Inc.'>FET</a>) <font color=\"red\">-10%</font>. Venator Materials (NYSE:<a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials PLC'>VNTR</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445158\" data-linked=\"Amyris and Key Energy Services among Energy/Materials losers\" data-tweet=\"$BRN $AMRS $KEG - Amyris and Key Energy Services among Energy/Materials losers https://seekingalpha.com/news/3445158-amyris-and-key-energy-services-among-energy-materials-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445158-amyris-and-key-energy-services-among-energy-materials-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445219\" data-ts=\"1553276823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMI\" target=\"_blank\">KMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445219-kinder-morgan-cut-to-neutral-j-p-morgan-after-34-ytd-return\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinder Morgan cut to Neutral at J.P. Morgan after 34% YTD return</a></h4><ul><li>Kinder Morgan (<a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color='red'>-2.6%</font>) slides after J.P. Morgan's Jeremy Tonet <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Kinder+Morgan+%28KMI%29+to+Neutral/15287437.html\" target=\"_blank\">downgrades</a> shares to Neutral from Overweight with a $21 price target, seeing a more balanced risk/reward profile and less upside potential relative to peers following the stock's 34% YTD total return.</li><li>KMI has made progress in cleaning up its balance sheet with cash it saved after cutting its dividend in 2015, Tonet says while also noting the company also has one of the lowest earnings growth profiles of the group.</li><li>Tonet prefers PPL Corp. (NYSE:<a href='https://seekingalpha.com/symbol/PPL' title='PPL Corporation'>PPL</a>), Williams (NYSE:<a href='https://seekingalpha.com/symbol/WMB' title='The Williams Companies, Inc.'>WMB</a>) and Plains GP Holdings (NYSE:<a href='https://seekingalpha.com/symbol/PAGP' title='Plains GP Holdings, L.P.'>PAGP</a>) in the North American Energy Infrastructure C-Corps space.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445219\" data-linked=\"Kinder Morgan cut to Neutral at J.P. Morgan after 34% YTD return\" data-tweet=\"$KMI $PPL $WMB - Kinder Morgan cut to Neutral at J.P. Morgan after 34% YTD return https://seekingalpha.com/news/3445219-kinder-morgan-cut-to-neutral-j-p-morgan-after-34-ytd-return?source=tweet\" data-url=\"https://seekingalpha.com/news/3445219-kinder-morgan-cut-to-neutral-j-p-morgan-after-34-ytd-return\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445154\" data-ts=\"1553275195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TORC\" target=\"_blank\">TORC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445154-restorbio-closes-50m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ResTORbio closes $50M capital raise</a></h4><ul><li>Thinly traded resTORbio (<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a> <font color=\"green\">+0.9%</font>) bucks the broad market's sour mood on 70% higher volume. It just <a href=\"https://seekingalpha.com/pr/17452755-restorbio-inc-announces-closing-public-offering-common-stock\" target=\"_blank\">announced</a> that it has closed its public offering of 7.2M common shares at $6.95 per share yielding gross proceeds of ~$50M.</li><li>Underwriters have a 30-day option to purchase up to an additional ~1.1M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445154\" data-linked=\"ResTORbio closes $50M capital raise\" data-tweet=\"$TORC - ResTORbio closes $50M capital raise https://seekingalpha.com/news/3445154-restorbio-closes-50m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3445154-restorbio-closes-50m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445151\" data-ts=\"1553274867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445151-disney-surprises-industry-shuttering-fox-2000-label\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney surprises industry by shuttering Fox 2000 label</a></h4><ul>   <li>One eye-opening move in the structural transition taking place at the former Twenty-First Century Fox entertainment studios is Disney's (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color=\"red\">-0.9%</font>) decision to shutter Fox 2000, the film label that found mid-budget successes with films like <i>The Fault in Our Stars, The Devil Wears Prada</i> and <i>Hidden Figures.</i></li>    <li>Observers acknowledge that some closures were bound to happen, with Disney taking control of nearly a dozen separate film brands, but were surprised it hit Fox 2000.</li>    <li>\"As a life time fan of all things Disney, this is difficult for me to say, but I think the shuttering of Fox 2000 is going to <a href=\"https://www.hollywoodreporter.com/news/as-layoffs-arrive-disney-fox-staff-voice-frustrations-1196346\" target=\"_blank\">go down as the one big mistake</a> the Mouse has made in an otherwise flawless strategy,\" says Marty Bowen, producer of <i>The Fault in Our Stars.</i></li>    <li>Meanwhile, at the new Fox Corp. (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color=\"red\">-3%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color=\"red\">-2.7%</font>), more analysts are coming in with revamped coverage: Barclays has reinstated coverage at Equal Weight, with a price target of $40; that implies 2.7% upside from current FOXA pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445151\" data-linked=\"Disney surprises industry by shuttering Fox 2000 label\" data-tweet=\"$FOX $FOXA $DIS - Disney surprises industry by shuttering Fox 2000 label https://seekingalpha.com/news/3445151-disney-surprises-industry-shuttering-fox-2000-label?source=tweet\" data-url=\"https://seekingalpha.com/news/3445151-disney-surprises-industry-shuttering-fox-2000-label\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445150\" data-ts=\"1553274617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBM\" target=\"_blank\">HBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445150-hudbays-rosemont-mine-plan-approved-u-s-forest-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudbay&#39;s Rosemont mine plan approved by U.S. Forest Service</a></h4><ul><li>Hudbay Minerals' (<a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc.'>HBM</a> <font color=\"red\">-3.9%</font>) proposed Rosemont copper mine <a href=\"https://tucson.com/news/local/forest-service-approves-operating-plan-for-rosemont-mine/article_f8bc671e-4c01-11e9-ab4f-a3a47525224e.html\" target=\"_blank\">clears its final administrative hurdle</a>, as the U.S. Forest Service approves the company's mine plan of operations for the project.</li><li>The plan details how HBM plans to operate the  $1.9B project to remove copper and other minerals from the open  pit.</li><li><a href=\"https://seekingalpha.com/news/3441372-hudbay-plus-6-percent-rosemont-mine-wins-final-permit-needed-construction\" target=\"_blank\">Earlier this month</a>, the Army Corps of Engineers approved a federal Clean Water Act permit for the project.</li><li>The mine, when completed, is expected to produce 112K tons/year of copper  concentrate with an anticipated 20-year lifespan.</li><li>Wheaton Precious Metals (<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp.'>WPM</a> <font color=\"green\">+1%</font>) has a metals purchase agreement  on the Rosemont project in exchange for an upfront $230M cash payment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445150\" data-linked=\"Hudbay&#39;s Rosemont mine plan approved by U.S. Forest Service\" data-tweet=\"$HBM $WPM - Hudbay&#39;s Rosemont mine plan approved by U.S. Forest Service https://seekingalpha.com/news/3445150-hudbays-rosemont-mine-plan-approved-u-s-forest-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3445150-hudbays-rosemont-mine-plan-approved-u-s-forest-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445149\" data-ts=\"1553274324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445149-medley-management-only-financial-gainers-leju-holdings-and-u-s-global-investors-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medley Management only financial gainers; Leju Holdings and U.S. Global Investors among losers</a></h4><ul><li><b>Gainers:</b> Medley Management (NYSE:<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management Inc.'>MDLY</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> CorePoint Lodging (NYSE:<a href='https://seekingalpha.com/symbol/CPLG' title='CorePoint Lodging Inc.'>CPLG</a>) <font color=\"red\">-27%</font>. Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"red\">-24%</font>. Leju Holdings (NYSE:<a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a>) <font color=\"red\">-11%</font>. Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a>) <font color=\"red\">-10%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445149\" data-linked=\"Medley Management only financial gainers; Leju Holdings and U.S. Global Investors among losers\" data-tweet=\"$MDLY $CPLG $LYL - Medley Management only financial gainers; Leju Holdings and U.S. Global Investors among losers https://seekingalpha.com/news/3445149-medley-management-only-financial-gainers-leju-holdings-and-u-s-global-investors-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445149-medley-management-only-financial-gainers-leju-holdings-and-u-s-global-investors-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445147\" data-ts=\"1553273994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445147-hp-lynch-head-for-londons-high-court\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP, Lynch head for London&#39;s High Court</a></h4><ul><li>HP (<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a> <font color='red'>-3%</font>) and Autonomy founder Mike Lynch <a href=\"https://www.reuters.com/article/us-autonomy-hp-lynch/autonomy-founder-lynch-set-for-5-billion-hewlett-packard-court-showdown-idUSKCN1R325U?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FbusinessNews+%28Business+News%29\" target=\"_blank\">will face off</a> in London's High Court on Monday for the latest step of a $5B showdown stretching back over six years.</li><li>HP accuses Lynch and former colleague Sushovan Hussain of inflating the value of big data firm Autonomy before selling it to HP.</li><li>Lynch denies the claims, blames the failure of the $11B acquisition on HP's mismanagement, and is counter-suing for more than $160M in loss and damages.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445147\" data-linked=\"HP, Lynch head for London&#39;s High Court\" data-tweet=\"$HPQ - HP, Lynch head for London&#39;s High Court https://seekingalpha.com/news/3445147-hp-lynch-head-for-londons-high-court?source=tweet\" data-url=\"https://seekingalpha.com/news/3445147-hp-lynch-head-for-londons-high-court\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445144\" data-ts=\"1553273523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445144-lexicon-pharma-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Lexicon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"red\">-5.3%</font>) pending the release of news, a near-certainty that it pertains to the expected FDA nod for Sanofi's (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color=\"red\">-2.6%</font>) oral Zynquista (sotagliflozin) for type 1 diabetes. Today is the agency's action date.</li><li>Sanofi in-licensed the dual SGLT-1 &amp; 2 inhibitor from Lexicon in November 2015.</li><li>Approval should trigger a milestone payment to LXRX.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445144\" data-linked=\"Lexicon Pharma shares halted pending news\" data-tweet=\"$LXRX $SNY - Lexicon Pharma shares halted pending news https://seekingalpha.com/news/3445144-lexicon-pharma-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3445144-lexicon-pharma-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445145\" data-ts=\"1553273477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FENG\" target=\"_blank\">FENG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445145-phoenix-new-media-selling-32-of-yidian-owner-for-448m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phoenix New Media selling 32% of Yidian owner for $448M</a></h4><ul>   <li>Phoenix New Media (<a href=\"http://seekingalpha.com/symbol/FENG\" target=\"_blank\">FENG</a> <font color=\"red\">-5.2%</font>) has a definitive deal to <a href=\"https://seekingalpha.com/pr/17452879-phoenix-new-media-announces-definitive-agreement-sell-investment-yidian\" target=\"_blank\">sell 32% of Particle</a>, its entity that owns the popular Yidian Zixun news/lifestyle app.</li>    <li>The company has a share purchase agreement with Run Liang Tai Management to sell the share for $448M in cash.</li>    <li>That would leave Phoenix with about 5.63% of Particle; it currently holds 37.63%.</li>    <li>The buyers have paid a cash deposit of $100M.</li>    <li>The deal still needs shareholder approval at Phoenix and any approvals needed by other shareholders at Particle and the Hong Kong Stock Exchange.</li>    <li>\"We believe that selling partial ownership of Yidian to a strategic buyer will help maximize Yidian's growth potential as well as fuel our own growth in the long-run,\" says Phoenix CEO Shuang Liu.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445145\" data-linked=\"Phoenix New Media selling 32% of Yidian owner for $448M\" data-tweet=\"$FENG - Phoenix New Media selling 32% of Yidian owner for $448M https://seekingalpha.com/news/3445145-phoenix-new-media-selling-32-of-yidian-owner-for-448m?source=tweet\" data-url=\"https://seekingalpha.com/news/3445145-phoenix-new-media-selling-32-of-yidian-owner-for-448m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445143\" data-ts=\"1553272926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445143-smartsheetminus-9-on-first-neutral-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet -9% on first Neutral rating</a></h4><ul><li>D.A. Davidson says Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>) is \"fully valued\" and starts at a Neutral rating, becoming the first of the nine firms covering the company not to have a Buy-equivalent view.</li><li>Analyst Rishi Jaluria advises to \"wait for a better entry point\" and sets his price target at $45.</li><li>Smartsheet shares are <font color=\"red\">down 8.7%</font> to $41.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445143\" data-linked=\"Smartsheet -9% on first Neutral rating\" data-tweet=\"$SMAR - Smartsheet -9% on first Neutral rating https://seekingalpha.com/news/3445143-smartsheetminus-9-on-first-neutral-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3445143-smartsheetminus-9-on-first-neutral-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445141\" data-ts=\"1553272898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445141-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers: </strong>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+40%</font>. Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>) <font color=\"green\">+23%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+18%</font>. Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited'>IMMP</a>) <font color=\"green\">+17%</font>. CounterPath (NASDAQ:<a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a>) <font color=\"green\">+12%</font>. Destination Maternity (NASDAQ:<a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>) <font color=\"green\">+11%</font>. Netshoes (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"green\">+11%</font>. AC Immune SA (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a>) <font color=\"green\">+11%</font>. MDC Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCA' title='MDC Partners Inc.'>MDCA</a>) <font color=\"green\">+10%</font>. Urban Tea (NASDAQ:<a href='https://seekingalpha.com/symbol/MYT' title='Urban Tea, Inc.'>MYT</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a>) <font color=\"red\">-55%</font>. CorePoint Lodging (NYSE:<a href='https://seekingalpha.com/symbol/CPLG' title='CorePoint Lodging Inc.'>CPLG</a>) <font color=\"red\">-27%</font>. Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"red\">-24%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-16%</font>. Superconductor Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a>) <font color=\"red\">-15%</font>. Zuora (NYSE:<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>) <font color=\"red\">-15%</font>. Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <font color=\"red\">-14%</font>. JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"red\">-13%</font>. Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) <font color=\"red\">-13%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445141\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$SEEL $HIBB $BPTH - Microcaps dominate midday movers https://seekingalpha.com/news/3445141-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445141-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445135\" data-ts=\"1553271271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPG\" target=\"_blank\">PPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445135-ppg-sherwin-williams-fall-sharply-following-j-p-morgan-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PPG, Sherwin-Williams fall sharply following J.P. Morgan downgrades</a></h4><ul><li>Shares of PPG Industries (<a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a> <font color='red'>-5.2%</font>) and Sherwin-Williams (<a href='https://seekingalpha.com/symbol/SHW' title='The Sherwin-Williams Company'>SHW</a> <font color='red'>-2.7%</font>) both sink after receiving downgrades from J.P. Morgan's Jeffrey Zekauskas.</li><li>The analyst <a href=\"https://thefly.com/thestreet/realmoney/index.php/PPGid2882963/PPG-JPMorgan-downgrades-PPG-to-Underweight-says-company-split-unlikely\" target=\"_blank\">cuts PPG to Underweight</a> from Neutral with a $106 price target, saying shares have been drifting higher in 2019 as the market continues to prefer higher quality and less cyclical materials companies, but general economic business conditions are \"arguably weaker than they have been because of decreased rates of economic growth in China and in Europe.\"</li><li>Also, Zekauskas thinks PPG is unlikely to split itself into two different coatings entities as Trian has suggested.</li><li>Meanwhile, Zekauskas <a href=\"https://www.cnbc.com/2019/03/22/here-are-the-biggest-analyst-calls-of-the-day-best-buy-chipotle-sherwin-williams--more.html\" target=\"_blank\">downgrades SHW to Neutral</a> from Overweight with a $435 price target citing valuation, saying SHW is a high-quality company that trades at multiples that are among the highest in the coatings universe.</li><li>JPM thinks Q1 volume trends are moving in the right direction, as strong January paint store trends from a backlog of paint contractor work did not continue into February, while demand trends in March, typically the strongest month of the quarter, may not be appreciably higher with wet weather likely a factor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445135\" data-linked=\"PPG, Sherwin-Williams fall sharply following J.P. Morgan downgrades\" data-tweet=\"$PPG $SHW - PPG, Sherwin-Williams fall sharply following J.P. Morgan downgrades https://seekingalpha.com/news/3445135-ppg-sherwin-williams-fall-sharply-following-j-p-morgan-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3445135-ppg-sherwin-williams-fall-sharply-following-j-p-morgan-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445132\" data-ts=\"1553270445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445132-avon-products-and-yeti-holdings-in-consumer-gainers-eastman-kodak-and-iconix-brand-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Products and YETI Holdings in consumer gainers; Eastman Kodak and Iconix Brand among losers</a></h4><ul><li><b>Gainers: </b>Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+6%</font>. YETI Holdings (NYSE:<a href='https://seekingalpha.com/symbol/YETI' title='YETI Holdings, Inc.'>YETI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Caleres (NYSE:<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a>) <font color=\"red\">-10%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"red\">-8%</font>. Reed's (NYSEMKT:<a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a>) <font color=\"red\">-8%</font>. Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Company'>KODK</a>) <font color=\"red\">-7%</font>. Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445132\" data-linked=\"Avon Products and YETI Holdings in consumer gainers; Eastman Kodak and Iconix Brand among losers\" data-tweet=\"$AVP $YETI $CAL - Avon Products and YETI Holdings in consumer gainers; Eastman Kodak and Iconix Brand among losers https://seekingalpha.com/news/3445132-avon-products-and-yeti-holdings-in-consumer-gainers-eastman-kodak-and-iconix-brand-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3445132-avon-products-and-yeti-holdings-in-consumer-gainers-eastman-kodak-and-iconix-brand-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445129\" data-ts=\"1553270182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUO\" target=\"_blank\">ZUO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445129-zuora-announces-five-new-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zuora announces five new patents</a></h4><ul><li>Zuora (NYSE:<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>) <a href=\"https://seekingalpha.com/pr/17452801-zuora-adds-five-new-u-s-patents-accelerate-growth-subscription-economy\" target=\"_blank\">announces </a>adding five new patents in FY19 that include \"a method for projecting recognizable revenue based on the likelihood of deviation, a method of triaging system assets in a multi-tenant architecture, and a variety of methods for optimizing product and system performance, product and security.\"</li><li>The company says the patents offer innovative technology that will power the subscription economy.</li><li>Zuora shares are <font color=\"red\">down 16%</font> after yesterday's Q4 report. Analysts were broadly positive after the print with Canaccord Genuity's Richard Davis saying \"there was absolutely nothing we heard on the call or the call back that shakes our confidence\" in the Buy recommendation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444936-zuora-minus-9_6-percent-mixed-q4-print\" target=\"_blank\">Zuora -9.6% after mixed Q4 print</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445129\" data-linked=\"Zuora announces five new patents\" data-tweet=\"$ZUO - Zuora announces five new patents https://seekingalpha.com/news/3445129-zuora-announces-five-new-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3445129-zuora-announces-five-new-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445127\" data-ts=\"1553269938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445127-tesla-target-cut-to-180-cowen-saying-low-cost-model-3-needed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla target cut to $180 at Cowen, saying low-cost Model 3 needed</a></h4><ul><li>Demand for Tesla\u2019s (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-3%</font>) Model 3 sedan <a href=\"https://finance.yahoo.com/news/tesla-needs-low-cost-model-133706015.html\" target=\"_blank\">likely will remain soft</a> in the U.S. until the release of the lower-priced $35K model next quarter, Cowen analyst Jeffrey Osborne says in reiterating his Underperform rating and cutting his stock price target to $180 from $200.</li><li>Osborne cuts his Q1 Model 3 delivery forecast to 47.5K from 55K and his Model S/X delivery outlook to 18K from 21.5K to reflect both state government and third party data that he says suggests deliveries will be weaker than previous expectations even with the \"typical end of quarter frantic push.\"</li><li>The biggest risk to the revised estimates may be China, where delivery expectations and customs clearance are less transparent, Osborne says.</li><li>TSLA typically reports quarterly delivery and production data within a few days of the end of the period; Osborne says a high vehicle-in-transit number likely would indicate delivery logistic challenges in Europe and China, similar to what was seen in the U.S. market last year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445127\" data-linked=\"Tesla target cut to $180 at Cowen, saying low-cost Model 3 needed\" data-tweet=\"$TSLA - Tesla target cut to $180 at Cowen, saying low-cost Model 3 needed https://seekingalpha.com/news/3445127-tesla-target-cut-to-180-cowen-saying-low-cost-model-3-needed?source=tweet\" data-url=\"https://seekingalpha.com/news/3445127-tesla-target-cut-to-180-cowen-saying-low-cost-model-3-needed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>646&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445123\" data-ts=\"1553268573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDN\" target=\"_blank\">IDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445123-intellicheckplus-4-post-q4-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intellicheck +4% post Q4 earnings beat</a></h4><ul><li>Intellicheck (<a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck, Inc.'>IDN</a> <font color=\"green\">+4.1%</font>) reported Q4 revenue growth of 37.1% to $1.33M, with SaaS revenue up 45% Y/Y.</li><li>Q4 Gross profit as a percentage of revenues improved to 93.1%, vs 89.4% in the prior year comparable period.</li><li>Q4 Adj. EBITDA was loss of $632.7k, compare to loss of $1.33M in Q4 2017.</li><li>Net cash used in operating activities YTD was $4.22M, compared to $3.75M a year ago.</li><li>Company had cash in hand of $4.37M as of December 31, 2018, compared to $18.01M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444910-intellicheck-mobilisa-beats-0_03-beats-revenue\" target=\"_blank\">Intellicheck Mobilisa beats by $0.03, beats on revenue</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445123\" data-linked=\"Intellicheck +4% post Q4 earnings beat\" data-tweet=\"$IDN - Intellicheck +4% post Q4 earnings beat https://seekingalpha.com/news/3445123-intellicheckplus-4-post-q4-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3445123-intellicheckplus-4-post-q4-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445121\" data-ts=\"1553268368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445121-alibaba-tencent-team-to-take-on-didi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba, Tencent team to take on Didi</a></h4><ul><li>Alibaba (<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='red'>-2.4%</font>), Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holdings Limited'>OTCPK:TCEHY</a>,<a href='https://seekingalpha.com/symbol/TCTZF' title='Tencent Holdings Limited'>OTCPK:TCTZF</a>), Suning, and car makers set up a $1.5B Chinese ride-hailing venture to take on regional giant Didi Chuxing (<a href='https://seekingalpha.com/symbol/DIDI' title='Didi Chuxing'>DIDI</a>).</li><li>Chongqing Changan Automobile says it chipped in $238.36M into the investment company. Automakers FAW and Dongfeng Motor are also involved, and the three will each have a 15% stake. Suning will get the largest piece at 19% while Alibaba and Tencent split the remainder.</li><li>Didi takes 90% of the bookings in the $23B Chinese ride-hail market, according to Bain &amp; Co. research. Did has financial backing from SoftBank and Uber plus JVs with BAIC and Volkswagen.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445121\" data-linked=\"Alibaba, Tencent team to take on Didi\" data-tweet=\"$BABA $TCEHY $TCTZF - Alibaba, Tencent team to take on Didi https://seekingalpha.com/news/3445121-alibaba-tencent-team-to-take-on-didi?source=tweet\" data-url=\"https://seekingalpha.com/news/3445121-alibaba-tencent-team-to-take-on-didi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445118\" data-ts=\"1553267590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445118-nokia-responds-alcatel-lucent-probe-shouldnt-material-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia responds: Alcatel-Lucent probe shouldn&#39;t have material impact</a></h4><ul>   <li>In a new statement on <a href=\"https://seekingalpha.com/news/3444940-nokia-notes-discovery-compliance-issue-alcatel-lucent\" target=\"_blank\">Alcatel-Lucent compliance issues</a> that emerged in its annual 20-F filing, Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color=\"red\">-5.8%</font>) says it's clarifying that its probe is <a href=\"https://seekingalpha.com/pr/17452792-nokia-comments-market-rumors-related-annual-report-form-20-f\" target=\"_blank\">not expected to have a material impact</a>.</li>    <li>That's despite risk-factor language in the filing that potential monetary fines could have a material adverse effect.</li>    <li>The probe is \"not expected to have a material impact on Nokia. We have seen no evidence that would suggest that criminal penalties would apply in this case, and we believe it is highly likely that any penalties that might apply would be limited and immaterial.\"</li>    <li>\"Out of an abundance of caution and in the spirit of transparency, Nokia has contacted the relevant regulatory authority regarding this review,\" it says.</li>    <li>And for audit purposes, it notes overall group materiality is defined at \u20ac125M as disclosed in the annual report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445118\" data-linked=\"Nokia responds: Alcatel-Lucent probe shouldn&#39;t have material impact\" data-tweet=\"$NOK - Nokia responds: Alcatel-Lucent probe shouldn&#39;t have material impact https://seekingalpha.com/news/3445118-nokia-responds-alcatel-lucent-probe-shouldnt-material-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3445118-nokia-responds-alcatel-lucent-probe-shouldnt-material-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445115\" data-ts=\"1553267262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TS\" target=\"_blank\">TS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445115-tenaris-to-buy-u-s-steel-pipe-producer-from-russias-tmk-for-1_2b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenaris to buy U.S. steel pipe producer from Russia&#39;s TMK for $1.2B</a></h4><ul><li>Tenaris (<a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a> <font color=\"green\">+2.4%</font>) <a href=\"https://www.globenewswire.com/news-release/2019/03/22/1759343/0/en/Tenaris-to-Acquire-IPSCO-Tubulars-from-TMK.html\" target=\"_blank\">agrees to acquire</a> U.S.-based steel pipe manufacturer IPSCO Tubulars from Russia's PAO TMK for $1.21B.</li><li>TS says the deal will strengthen its position in the U.S. market, extending its product offering and expanding its service footprint.</li><li>TMK previously considered listing IPSCO in a $615M IPO but postponed the plan last year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445115\" data-linked=\"Tenaris to buy U.S. steel pipe producer from Russia&#39;s TMK for $1.2B\" data-tweet=\"$TS - Tenaris to buy U.S. steel pipe producer from Russia&#39;s TMK for $1.2B https://seekingalpha.com/news/3445115-tenaris-to-buy-u-s-steel-pipe-producer-from-russias-tmk-for-1_2b?source=tweet\" data-url=\"https://seekingalpha.com/news/3445115-tenaris-to-buy-u-s-steel-pipe-producer-from-russias-tmk-for-1_2b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445113\" data-ts=\"1553267161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHL\" target=\"_blank\">CHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445113-china-mobileminus-1_9-analysts-pull-back-following-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Mobile -1.9% as analysts pull back following earnings</a></h4><ul>   <li>China Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a>) is <font color=\"red\">off 1.9%</font> following analyst reaction to its earnings, where it topped expectations but failed to issue much clarity on its 5G capital spending plans.</li>    <li>Shares fell 5% on NYSE yesterday, and the stock is shedding a few bulls from its corner.</li>    <li>Bullish CLSA downgraded the shares to Outperform.</li>    <li>Meanwhile two others have headed to the sidelines. HSBC has downgraded to Hold, and set its price target at HK$85 (implying 3.8% upside).</li>    <li>And Bank of China International also cut to Hold, and set its price target to HK$86.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445113\" data-linked=\"China Mobile -1.9% as analysts pull back following earnings\" data-tweet=\"$CHL - China Mobile -1.9% as analysts pull back following earnings https://seekingalpha.com/news/3445113-china-mobileminus-1_9-analysts-pull-back-following-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3445113-china-mobileminus-1_9-analysts-pull-back-following-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445112\" data-ts=\"1553266972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445112-seelos-therapeutics-leads-healthcare-gainers-conatus-pharmaceuticals-and-sellas-life-sciences\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos Therapeutics leads healthcare gainers; Conatus Pharmaceuticals and SELLAS Life Sciences Group among losers</a></h4><ul><li><b>Gainers: </b>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+28%</font>. Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited'>IMMP</a>) <font color=\"green\">+19%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+16%</font>. Neurotrope (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRP' title='Neurotrope, Inc.'>NTRP</a>) <font color=\"green\">+14%</font>. India Globalization Capital (NYSEMKT:<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc.'>IGC</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers: </b>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a>) <font color=\"red\">-55%</font>. SELLAS Life Sciences Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) <font color=\"red\">-10%</font>. Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <font color=\"red\">-9%</font>. Sienna Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals, Inc.'>SNNA</a>) <font color=\"red\">-7%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445112\" data-linked=\"Seelos Therapeutics leads healthcare gainers; Conatus Pharmaceuticals and SELLAS Life Sciences Group among losers\" data-tweet=\"$SEEL $IMMP $BPTH - Seelos Therapeutics leads healthcare gainers; Conatus Pharmaceuticals and SELLAS Life Sciences Group among losers https://seekingalpha.com/news/3445112-seelos-therapeutics-leads-healthcare-gainers-conatus-pharmaceuticals-and-sellas-life-sciences?source=tweet\" data-url=\"https://seekingalpha.com/news/3445112-seelos-therapeutics-leads-healthcare-gainers-conatus-pharmaceuticals-and-sellas-life-sciences\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445105\" data-ts=\"1553265505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOFO\" target=\"_blank\">SOFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445105-sonic-foundry-tanks-on-preliminary-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic Foundry tanks on preliminary Q1 results</a></h4><ul><li>Sonic Foundry (<a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTCPK:SOFO</a>) reports billings of $6.1M (-20% Y/Y) in Q119.</li><li>Total revenues were $7.5M ($8.4M without distribution impact) vs. a $8.9M in the Q118.</li><li>Gross margin was $5.7M or 75% of sales compared to $6.5M, or 73% of sales year ago.</li><li>Adjusted EBITDA of $(1.2)M ($(0.56)M without distribution impact), compared to $(0.34)M in the Q118.</li><li>Net loss of $(1.8)M ($(1.1)M without distribution impact), or $(0.36) per share compared to net income of $0.32M, or $0.06 per share in the Q118 (net income in the Q118 benefited from a tax gain of $1.3M related to tax legislation changes in Dec. 2017).</li><li><a href=\"https://seekingalpha.com/pr/17452234-sonic-foundry-announces-preliminary-fiscal-2019-first-quarter-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445105\" data-linked=\"Sonic Foundry tanks on preliminary Q1 results\" data-tweet=\"$SOFO - Sonic Foundry tanks on preliminary Q1 results https://seekingalpha.com/news/3445105-sonic-foundry-tanks-on-preliminary-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3445105-sonic-foundry-tanks-on-preliminary-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445103\" data-ts=\"1553265088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445103-conatus-flop-fails-to-move-nash-players\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus flop fails to move NASH players</a></h4><ul><li>The broad market's down move notwithstanding, most companies working on NASH therapies have moved in lockstep with market following Conatus Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a> <font color=\"red\">-56%</font>) <a href=\"https://seekingalpha.com/news/3445040-conatus-pharmas-emricasan-flunks-late-stage-nash-study-shares-54-percent-premarket\" target=\"_blank\">failed Phase 2b study</a> of emricasan. Many times investors perceive that one company's pain is another's gain.</li><li>Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color=\"green\">+4.5%</font>) is the lone exception, albeit on low volume.</li><li>Selected tickers: Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color=\"red\">-0.8%</font>), Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a> <font color=\"red\">-5.4%</font>), Can-Fite BioPharma (<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a> <font color=\"red\">-1.5%</font>), Lipocine (<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color=\"red\">-1.7%</font>), Intercept Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a> <font color=\"red\">-1.9%</font>), CymaBay Therapeutics (<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics, Inc.'>CBAY</a> <font color=\"red\">-3.6%</font>), Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-0.4%</font>), Enanta Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color=\"red\">-2%</font>), Genfit SA (<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit SA'>OTCPK:GNFTF</a> <font color=\"red\">-2%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-1.6%</font>), Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"red\">-0.5%</font>), Wave Life Sciences (<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a> <font color=\"red\">-0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445103\" data-linked=\"Conatus flop fails to move NASH players\" data-tweet=\"$CNAT $MDGL $VKTX - Conatus flop fails to move NASH players https://seekingalpha.com/news/3445103-conatus-flop-fails-to-move-nash-players?source=tweet\" data-url=\"https://seekingalpha.com/news/3445103-conatus-flop-fails-to-move-nash-players\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445099\" data-ts=\"1553264286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445099-best-buy-upped-oppenheimer-investors-dont-fully-appreciate-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy upped at Oppenheimer as investors don&#39;t fully appreciate changes</a></h4><ul><li>Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co., Inc.'>BBY</a> <font color='green'>+1.3%</font>) opens higher after Oppenheimer <a href=\"https://www.thestreet.com/markets/best-buy-upgraded-to-outperform-at-oppenheimer-14904281\" target=\"_blank\">upgrades shares to Outperform</a> from Perform with an $86 price target, saying investors are still not fully embracing the company's improved sales and earnings power.</li><li>BBY \"has undergone a significant transformation, whereby it evolved from a traditional chain of large-format superstores to one of retail's preeminent omni-channel operators, which utilizes digital well as a means to connect better with consumers and enhance underlying disciplines,\" Oppenheimer's Brian Nagel writes.</li><li>With online sales now consistently representing ~16% of BBY's domestic revenue, Nagel believes e-commerce is now a key sales driver.</li><li>Oppenheimer bumps its FY 2019 and 2020 EPS guidance for BBY to $5.70 and $6.18, respectively, vs. $5.54 and $5.80 previously.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445099\" data-linked=\"Best Buy upped at Oppenheimer as investors don&#39;t fully appreciate changes\" data-tweet=\"$BBY - Best Buy upped at Oppenheimer as investors don&#39;t fully appreciate changes https://seekingalpha.com/news/3445099-best-buy-upped-oppenheimer-investors-dont-fully-appreciate-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/3445099-best-buy-upped-oppenheimer-investors-dont-fully-appreciate-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445095\" data-ts=\"1553263624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLF\" target=\"_blank\">XLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445095-buying-panic-in-bonds-sinks-banks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buying panic in bonds sinks banks</a></h4><ul><li>Behind today's big move down in bond yields <a href=\"https://seekingalpha.com/news/3445015-german-10-year-yield-falls-zero-weak-manufacturing-report\" target=\"_blank\">was a plunge in</a> the German PMI to its weakest level since 2012. That sent the German 10-year Bund yield down into negative territory.</li><li>Alongside, the U.S. 10-year Treasury yield is off more than nine basis points to 2.44% - its lowest print in more than two years. That pretty much makes the U.S. yield curve flat (the 2-year is at 2.34%, and the Fed Funds target is 2.25%-2.5%). <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"green\">+1.35%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"red\">-2.7%</font></li><li>While the major U.S. averages are <font color=\"red\">down about 1%</font>, the financial sector (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-2.3%</font>) is being hit way harder. The SPDR Regional Banking ETF (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> <font color='red'>-3.4%</font>), The SPDR Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='red'>-3.3%</font>).</li><li>Individual players: Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-3.6%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-3.3%</font>), Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Company'>WFC</a> <font color='red'>-2.5%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='red'>-4.6%</font>), SunTrust (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='red'>-3%</font>), Comerica (<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Incorporated'>CMA</a> <font color='red'>-3.6%</font>), BB&amp;T (<a href='https://seekingalpha.com/symbol/BBT' title='BB&T Corporation'>BBT</a> <font color='red'>-2.9%</font>), Fifth Third (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color='red'>-2.7%</font>), Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='red'>-4.4%</font>), BNY Mellon (<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a> <font color='red'>-2.8%</font>), MetLife (<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a> <font color='red'>-3%</font>), Prudential (<a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a> <font color='red'>-2.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3445095\" data-linked=\"Buying panic in bonds sinks banks\" data-tweet=\"$XLF $KRE $KBE - Buying panic in bonds sinks banks https://seekingalpha.com/news/3445095-buying-panic-in-bonds-sinks-banks?source=tweet\" data-url=\"https://seekingalpha.com/news/3445095-buying-panic-in-bonds-sinks-banks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>368&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445088\" data-ts=\"1553263051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445088-twitter-shares-hot-amid-positive-ad-chatter-cleveland\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter shares hot amid positive ad chatter at Cleveland</a></h4><ul>   <li>A sharp move up in Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"green\">+4.2%</font>) is being attributed to positive chatter from Cleveland Research.</li>    <li>The firm is reportedly increasing estimates based on encouraging feedback from advertisers.</li>    <li>Twitter shares are <font color=\"green\">up 13.5%</font> YTD, trimming their decline over the past three months to <font color=\"red\">-3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445088\" data-linked=\"Twitter shares hot amid positive ad chatter at Cleveland\" data-tweet=\"$TWTR - Twitter shares hot amid positive ad chatter at Cleveland https://seekingalpha.com/news/3445088-twitter-shares-hot-amid-positive-ad-chatter-cleveland?source=tweet\" data-url=\"https://seekingalpha.com/news/3445088-twitter-shares-hot-amid-positive-ad-chatter-cleveland\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445083\" data-ts=\"1553262572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445083-vaalco-energy-announces-changes-in-company-leadership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaalco Energy announces changes in company leadership</a></h4><ul><li>Vaalco Energy (<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color=\"red\">-4.5%</font>) says that Phil Patman, Vaalco\u2019s Chief Financial Officer, has elected to resign from the Company, effective Mar. 31, 2019, to pursue other interests.</li><li>Elizabeth Prochnow, the Company\u2019s Chief Accounting Officer, has been appointed by the Board to the role of Chief Financial Officer effective April 1, 2019.</li><li>The company says that Mr. Patman\u2019s departure was not related to any issues regarding financial disclosures, accounting or legal matters.</li><li><a href=\"https://seekingalpha.com/pr/17452493-vaalco-energy-inc-announces-changes-company-leadership\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3445083\" data-linked=\"Vaalco Energy announces changes in company leadership\" data-tweet=\"$EGY - Vaalco Energy announces changes in company leadership https://seekingalpha.com/news/3445083-vaalco-energy-announces-changes-in-company-leadership?source=tweet\" data-url=\"https://seekingalpha.com/news/3445083-vaalco-energy-announces-changes-in-company-leadership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445081\" data-ts=\"1553262559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOOO\" target=\"_blank\">DOOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445081-brpplus-5_11-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BRP +5.11% post Q4 results</a></h4><ul><li>BRP (<a href='https://seekingalpha.com/symbol/DOOO' title='BRP Inc.'>DOOO</a> <font color=\"green\">+5.1%</font>) reports <a href=\"https://seekingalpha.com/pr/17452472-brp-reports-fourth-quarter-fiscal-year-2019-results\" target=\"_blank\">Q4</a> revenue growth of 22.8% Y/Y to C$1.51B.</li><li>Year-Round Products C$88.5M (+17.4% Y/Y); Seasonal Products C$140.4M (+32.1% Y/Y); Powersports PAC and OEM Engines C$15.5M (+8.2% Y/Y) &amp; Marine C$31.8M (+31.2% Y/Y).</li><li>North American retail sales for powersports vehicles and outboard engines increased by 7% Y/Y, the increase was driven by Year-Round Products.</li><li>Gross profit margin <font color=\"red\">declined by 80 bps</font> to 22.2%, due to higher commodity, production and distribution costs, partially offset by a higher volume of 3WV, snowmobiles and PAC sold.</li><li>Operating margin also <font color=\"red\">declined 120 bps</font> to 8.4% &amp; Normalized EBITDA<sup> </sup>margin also <font color=\"red\">declined 115 bps</font> to 12.08%.</li><li>The company acquired 100% of Alumacraft Holdings, Alumacraft Boat and 100% of Triton Industries.</li><li>BRP\u2019s subordinate voting shares were listed in the US on the Nasdaq Global Select Market under the symbol DOOO.</li><li>Approved a quarterly dividend of $0.10/share payable on April 12, 2019.</li><li><b>2020 Guidance: </b>Year-Round Products up 12% to 17%Y/Y; Seasonal Products flat to up 3% Y/Y; Powersports PAC and OEM Engines up 2% to 7% Y/Y; Marine up 15% to 20% Y/Y; Total Company Revenues up 7% to 11% Y/Y; Normalized EBITDA up 19% to 23% Y/Y; Normalized EPS 13% to 19% Y/Y &amp; Net Income of $340-365M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445003-brp-declares-0_10-dividend\" target=\"_blank\">BRP declares $0.10 dividend</a> (Mar. 22 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445004-brp-reports-q4-results\" target=\"_blank\">BRP reports Q4 results</a> (Mar. 22 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445081\" data-linked=\"BRP +5.11% post Q4 results\" data-tweet=\"$DOOO - BRP +5.11% post Q4 results https://seekingalpha.com/news/3445081-brpplus-5_11-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3445081-brpplus-5_11-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445078\" data-ts=\"1553262272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLK\" target=\"_blank\">BLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445078-blackrockminus-1_2-after-deal-to-buy-efront-for-1_3b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackRock -1.2% after deal to buy eFront for $1.3B</a></h4><ul><li>BlackRock (NYSE:<a href='https://seekingalpha.com/symbol/BLK' title='BlackRock, Inc.'>BLK</a>) <font color=\"red\">falls 1.2%</font> after<a href=\"https://seekingalpha.com/pr/17452712-blackrock-acquire-efront-industry-leading-alternatives-investment-software-provider\" target=\"_blank\"> agreeing to buy</a> 100% of the equity interests in eFront, an alternative investment management software firm, for $1.3B in cash.</li><li>The purchase adds to BlackRock's Aladdin investment operating platform used by more than 225 institutions; eFront serves more than 700 clients and provides technology for managing the alternatives investment lifecycle, including due diligence, portfolio planning, performance, and risk analysis.</li><li>The deal will be funded with a combination of existing corporate liquidity and debt and is expected to be minimally dilutive to EPS but not dilutive on a cash basis.</li><li>Separately from the acquisition, BlackRock entered an agreement to repurchase ~3.1M of its shares at $412.84 per share in a private transaction.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445035-blackrock-talks-buy-software-firm-efront-wsj\" target=\"_blank\">BlackRock in talks to buy software firm eFront: WSJ</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445078\" data-linked=\"BlackRock -1.2% after deal to buy eFront for $1.3B\" data-tweet=\"$BLK - BlackRock -1.2% after deal to buy eFront for $1.3B https://seekingalpha.com/news/3445078-blackrockminus-1_2-after-deal-to-buy-efront-for-1_3b?source=tweet\" data-url=\"https://seekingalpha.com/news/3445078-blackrockminus-1_2-after-deal-to-buy-efront-for-1_3b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445073\" data-ts=\"1553261400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445073-nokiaminus-5_1-in-reaction-to-alcatel-lucent-compliance-issue-look\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia -5.1% in reaction to Alcatel-Lucent compliance-issue look</a></h4><ul>   <li>Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) is <font color=\"red\">down 5.1%</font> premarket after disclosing it's <a href=\"https://seekingalpha.com/news/3444940-nokia-notes-discovery-compliance-issue-alcatel-lucent\" target=\"_blank\">found compliance issues</a> spurring a new investigation into its Alcatel-Lucent integration.</li>    <li>That note in its 20-F leaves much to investor imaginations. Nokia says it is scrutinizing particular transactions.</li>    <li>UBS analyst David Mulholland notes that there's little information at the moment to gauge any potential impact on the business.</li>    <li>But he notes concern that the issue is showing up now, more than two years after Nokia closed on the deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445073\" data-linked=\"Nokia -5.1% in reaction to Alcatel-Lucent compliance-issue look\" data-tweet=\"$NOK - Nokia -5.1% in reaction to Alcatel-Lucent compliance-issue look https://seekingalpha.com/news/3445073-nokiaminus-5_1-in-reaction-to-alcatel-lucent-compliance-issue-look?source=tweet\" data-url=\"https://seekingalpha.com/news/3445073-nokiaminus-5_1-in-reaction-to-alcatel-lucent-compliance-issue-look\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445068\" data-ts=\"1553260981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445068-lululemonminus-2-wedbush-downgrade-sees-less-margin-upside-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon -2% as Wedbush downgrade sees less margin upside ahead</a></h4><ul><li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) <font color=\"red\">-2.2%</font> pre-market after Wedbush <a href=\"https://thefly.com/thestreet/realmoney/index.php/LULUid2883101/LULU-Lululemon-downgraded-to-Neutral-from-Outperform-at-Wedbush\" target=\"_blank\">downgrades shares to Neutral</a> from Outperform with a $155 price target, cut from $176.</li><li>Wedbush's Jen Redding says while she continues to see LULU as best in class among specialty retailers, she is moving to the sidelines in anticipation of potentially less margin upside ahead as she now forecasts gross margin below Wall Street estimates, drawing on data  points including assortment, average price and average full price  ticket value.</li><li>Redding expects measured guidance for the company, \"as a turbulent February likely hits LULU just as hard as the rest of retail, which may be taken less positively by investors given the notable growth metrics and margin expansion the retailer has typically posted in recent quarters.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3445068\" data-linked=\"Lululemon -2% as Wedbush downgrade sees less margin upside ahead\" data-tweet=\"$LULU - Lululemon -2% as Wedbush downgrade sees less margin upside ahead https://seekingalpha.com/news/3445068-lululemonminus-2-wedbush-downgrade-sees-less-margin-upside-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3445068-lululemonminus-2-wedbush-downgrade-sees-less-margin-upside-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445067\" data-ts=\"1553260872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445067-dnr-yrcw-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DNR, YRCW among premarket gainers</a></h4><ul><li>Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited'>IMMP</a>) <font color=\"green\">+50%</font> on eftilagimod alpha in cancer <a href=\"https://seekingalpha.com/news/3445032-immutep-nabs-patent-u-s-eftilagimod-alpha-cancer-shares-49-percent-premarket\" target=\"_blank\">patent</a> in US.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+31%</font>.</li><li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+26%</font>.</li><li>Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>) <font color=\"green\">+25%</font>.</li><li>One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+21%</font> on <a href=\"https://seekingalpha.com/news/3444911-one-stop-systems-beats-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Neurotrope (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRP' title='Neurotrope, Inc.'>NTRP</a>) <font color=\"green\">+10%.</font></li><li>Denbury Resources (NYSE:<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a>) <font color=\"green\">+6%</font> on terminating merger <a href=\"https://seekingalpha.com/news/3444968-penn-virginia-denbury-terminate-merger-agreement\" target=\"_blank\">agreement</a>.</li><li>HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) <font color=\"green\">+7%</font>.</li><li>YRC Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide Inc.'>YRCW</a>) <font color=\"green\">+5% </font>on <a href=\"https://seekingalpha.com/news/3445036-yrc-worldwide-teamsters-reach-tentative-contract-deal\" target=\"_blank\">tentative agreement</a> with the Teamsters.</li><li>Performance Shipping (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Performance Shipping Inc.'>DCIX</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445067\" data-linked=\"DNR, YRCW among premarket gainers\" data-tweet=\"$IMMP $BPTH $SEEL - DNR, YRCW among premarket gainers https://seekingalpha.com/news/3445067-dnr-yrcw-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445067-dnr-yrcw-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445065\" data-ts=\"1553260681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445065-lumentumplus-4_8-jpmorgan-sees-iphone-volume-risk-subsiding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum +4.8% as JPMorgan sees iPhone volume risk subsiding</a></h4><ul>   <li>Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) is <font color=\"green\">up 4.8%</font> premarket as JPMorgan upgrades to Overweight, with higher earnings expectations as it sees iPhone volume stabilization mitigating a key risk.</li>    <li>The firm joins more than a dozen others in a near-universal bullish chorus.</li>    <li>It's got lower concerns about \"customer concentration with Apple\" after the phone shipment outlook stabilized, \"which should drive focus back to strong fundamentals in the core business,\" writes Samik Chatterjee. JPMorgan has boosted profit expectations for 2019-2021. (h/t Bloomberg)</li>    <li>It's raised its price target to $65 from $50, implying 25% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445065\" data-linked=\"Lumentum +4.8% as JPMorgan sees iPhone volume risk subsiding\" data-tweet=\"$LITE - Lumentum +4.8% as JPMorgan sees iPhone volume risk subsiding https://seekingalpha.com/news/3445065-lumentumplus-4_8-jpmorgan-sees-iphone-volume-risk-subsiding?source=tweet\" data-url=\"https://seekingalpha.com/news/3445065-lumentumplus-4_8-jpmorgan-sees-iphone-volume-risk-subsiding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445063\" data-ts=\"1553260581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445063-papa-johns-adds-shaquille-oneal-to-board-sharesplus-4_0\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s adds Shaquille O&#39;Neal to board; shares +4.0%</a></h4><ul><li>Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) <font color=\"green\">jumps 4.0%</font> in premarket trading after the pizza restaurant chain names Shaquille O'Neal to its board and enters a marketing agreement with the NBA champion.</li><li>O'Neal will also invest in nine Papa John's restaurants in the Atlanta area.</li><li>This isn't O'Neal's first foray into the restaurant business. He owns a Krispy Kreme Doughnuts franchise in Atlanta and he's the founder and owner of Big Chicken, a fast casual fried chicken restaurant in Las Vegas, and Shaquille's a fine dining restaurant in Los Angeles.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443146-papa-johns-adds-two-board\" target=\"_blank\">Papa John's adds two to the board</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445063\" data-linked=\"Papa John&#39;s adds Shaquille O&#39;Neal to board; shares +4.0%\" data-tweet=\"$PZZA - Papa John&#39;s adds Shaquille O&#39;Neal to board; shares +4.0% https://seekingalpha.com/news/3445063-papa-johns-adds-shaquille-oneal-to-board-sharesplus-4_0?source=tweet\" data-url=\"https://seekingalpha.com/news/3445063-papa-johns-adds-shaquille-oneal-to-board-sharesplus-4_0\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445060\" data-ts=\"1553260387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445060-zuo-nok-and-jks-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZUO, NOK and JKS among premarket losers</a></h4><ul><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a>) <font color=\"red\">-55%</font> after emricasan <a href=\"https://seekingalpha.com/news/3445040-conatus-pharmas-emricasan-flunks-late-stage-nash-study-shares-54-percent-premarket\" target=\"_blank\">flunks</a> late-stage NASH study</li><li>Superconductor Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a>) <font color=\"red\">-11%</font>.</li><li>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"red\">-8%</font>.</li><li>Zuora (NYSE:<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3444915-zuora-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) <font color=\"red\">-6%</font> after <a href=\"https://seekingalpha.com/news/3444940-nokia-notes-discovery-compliance-issue-alcatel-lucent\" target=\"_blank\">facing</a> compliance issue at Alcatel-Lucent.</li><li>JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3445008-jinkosolar-holding-misses-0_08-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Conformis (NASDAQ:<a href='https://seekingalpha.com/symbol/CFMS' title='Conformis, Inc.'>CFMS</a>) <font color=\"red\">-5%</font>.</li><li>Staffing 360 Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a>) <font color=\"red\">-4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3445060\" data-linked=\"ZUO, NOK and JKS among premarket losers\" data-tweet=\"$CNAT $SCON $MTFB - ZUO, NOK and JKS among premarket losers https://seekingalpha.com/news/3445060-zuo-nok-and-jks-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445060-zuo-nok-and-jks-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445059\" data-ts=\"1553260375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445059-biogen-and-eisai-launch-late-stage-study-of-ban2401-in-alzheimers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen and Eisai launch late-stage study of BAN2401 in Alzheimer&#39;s</a></h4><ul><li>Shrugging off modest <a href=\"https://seekingalpha.com/news/3373754-biogen-eisais-ban2401-shows-positive-effect-mid-stage-alzheimers-study-biib-6-percent-hours\" target=\"_blank\">mid-stage results</a> and Roche's decision to bail on its amyloid beta candidate crenezumab, Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) and development partner Eisai (<a href='https://seekingalpha.com/symbol/ESALY' title='Eisai Co., Ltd.'>OTCPK:ESALY</a>) announce the launch of a global Phase 3 clinical trial, Clarity AD, evaluating anti-amyloid beta protofibril monoclonal antibody BAN2401 in patients with early Alzheimer's disease &#40;AD&#41;.</li><li>Clarity AD will enroll 1,566 patients with mild cognitive impairment due to AD or mild AD dementia with confirmed amyloid pathology in the brain. The primary endpoint is the change from baseline in a scale called CDR-SB at month 18.</li><li>Additional efficacy measures include the ADCOMS and ADAS-cog scales and brain amyloid levels.</li><li>BIIB is down <font color=\"red\">1%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3373857-ac-immune-minus-12-percent-biogen-s-alzheimer-s-data-fails-impress\" target=\"_blank\">AC Immune -12% as Biogen\u2019s Alzheimer\u2019s data fails to impress</a> (July 25, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445059\" data-linked=\"Biogen and Eisai launch late-stage study of BAN2401 in Alzheimer&#39;s\" data-tweet=\"$BIIB $ESALY $ESALF - Biogen and Eisai launch late-stage study of BAN2401 in Alzheimer&#39;s https://seekingalpha.com/news/3445059-biogen-and-eisai-launch-late-stage-study-of-ban2401-in-alzheimers?source=tweet\" data-url=\"https://seekingalpha.com/news/3445059-biogen-and-eisai-launch-late-stage-study-of-ban2401-in-alzheimers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445056\" data-ts=\"1553260028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445056-senseonics-launches-eversense-access-program-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics launches the Eversense access program in U.S.</a></h4><ul> <li>Senseonics Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a>) has <a href=\"https://seekingalpha.com/pr/17452558-senseonics-launches-eversense-bridge-patient-access-program-u-s\" target=\"_blank\">launched</a> the Eversense Bridge Program in U.S.</li><li>Under the program, patients can access the Eversense continuous glucose monitoring &#40;CGM&#41; System, the       only long-term CGM that lasts up to 90 days, for only $99* plus the cost       of the sensor placement by the healthcare provider.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>                    </ul><div class=\"tiny-share-widget\" data-id=\"3445056\" data-linked=\"Senseonics launches the Eversense access program in U.S.\" data-tweet=\"$SENS - Senseonics launches the Eversense access program in U.S. https://seekingalpha.com/news/3445056-senseonics-launches-eversense-access-program-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3445056-senseonics-launches-eversense-access-program-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445050\" data-ts=\"1553258598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445050-biogen-downgrades-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Biogen downgrades in premarket analyst action</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) initiated with Buy rating and $27 (44% upside) price target at Stifel citing its allure as an acquisition target. Shares down <font color=\"red\">1%</font> premarket.</li><li>Varian Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/VAR' title='Varian Medical Systems, Inc.'>VAR</a>) upgraded to Outperform with a $162 (17% upside) price target at Baird.</li><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) downgraded to Underweight with a $210 (7% downside risk) price target at Morgan Stanley after its aducanumab flop. Downgraded to Neutral at Citigroup and UBS. Shares down <font color=\"red\">1%</font> premarket.</li><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a>) downgraded to Hold at SunTrust after its emricasan flop in NASH. Shares down <font color=\"red\">54% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445050\" data-linked=\"More Biogen downgrades in premarket analyst action\" data-tweet=\"$AMRN $VAR $BIIB - More Biogen downgrades in premarket analyst action https://seekingalpha.com/news/3445050-biogen-downgrades-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3445050-biogen-downgrades-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445046\" data-ts=\"1553257629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRZN\" target=\"_blank\">HRZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445046-horizon-technology-offering-prices-sharesminus-4_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Technology offering prices; shares -4.2%</a></h4><ul><li>Horizon Technology Finance's (NASDAQ:<a href='https://seekingalpha.com/symbol/HRZN' title='Horizon Technology Finance'>HRZN</a>) <a href=\"https://seekingalpha.com/pr/17452604-horizon-technology-finance-corporation-prices-public-offering-common-stock\" target=\"_blank\">public offering</a> of 2.0M shares of common stock prices at $12.14 per share for gross proceeds of $24.3M.</li><li>HRZN is trading <font color=\"red\">down 4.2%</font> to $11.98 in premarket trading.</li><li>Grants underwriters 30-day option to buy up to an additional 300,000 shares to cover overallotments, if any.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444947-horizon-technology-finance-minus-4_1-percent-capital-raise-start\" target=\"_blank\">Horizon Technology Finance -4.1% after capital raise start</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445046\" data-linked=\"Horizon Technology offering prices; shares -4.2%\" data-tweet=\"$HRZN - Horizon Technology offering prices; shares -4.2% https://seekingalpha.com/news/3445046-horizon-technology-offering-prices-sharesminus-4_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3445046-horizon-technology-offering-prices-sharesminus-4_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445041\" data-ts=\"1553256744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOV\" target=\"_blank\">LOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445041-spark-networks-to-buy-dating-app-zoosk-in-255m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spark Networks to buy dating app Zoosk in $255M deal</a></h4><ul><li>Spark Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/LOV' title='Spark Networks SE'>LOV</a>) <font color=\"green\">+9.2%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17452336-spark-networks-se-enters-definitive-agreement-acquire-zoosk-inc-creating-second-largest\" target=\"_blank\">agreeing to acquire</a> dating app company Zoosk for $255M in cash and stock.</li><li>Spark says the acquisition will create the second largest online dating platform in North America and the second largest publicly-listed dating company in the world, more than doubling its monthly paying subscribers to more than 1M globally.</li><li>The company says two-thirds of revenues will be generated in North America as a result of the deal, advancing its goal of building a growing and profitable presence of scale in the world's largest dating market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445041\" data-linked=\"Spark Networks to buy dating app Zoosk in $255M deal\" data-tweet=\"$LOV - Spark Networks to buy dating app Zoosk in $255M deal https://seekingalpha.com/news/3445041-spark-networks-to-buy-dating-app-zoosk-in-255m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3445041-spark-networks-to-buy-dating-app-zoosk-in-255m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445040\" data-ts=\"1553256569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445040-conatus-pharmas-emricasan-flunks-mid-stage-nash-study-shares-down-54-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus Pharma&#39;s emricasan flunks mid-stage NASH study; shares down 54% premarket</a></h4><ul><li>Nano cap Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a>) is down <font color=\"red\">54% </font>premarket on light volume on the heels of its release of <a href=\"https://www.sec.gov/Archives/edgar/data/1383701/000117184319001889/f8k_032119.htm\" target=\"_blank\">topline results</a> from a Phase 2b clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02686762?titles=encore-nf&amp;lead=conatus&amp;rank=1\" target=\"_blank\">ENCORE-NF</a>, evaluating emricasan in patients with nonalcoholic steatohepatitis &#40;NASH&#41; with fibrosis.</li><li>The study failed to achieve the primary endpoint of a statistically significant proportion of treated patients experiencing at least a one-stage improvement in fibrosis without worsening of NASH at week 72 compared to placebo. In fact, emricasan failed to keep up with placebo. The response rates in the 5 mg emricasan arm, the 50 mg emricasan arm and the control arm were 11.2%, 12.3%, and 19.0%, respectively.</li><li>CEO Steven Mento, Ph.D. <a href=\"https://seekingalpha.com/pr/17452187-conatus-announces-top-line-results-encore-nf-phase-2b-clinical-trial-nash-fibrosis\" target=\"_blank\">says</a>, \u201cAlthough emricasan did not have the desired effect in these earlier-stage NASH fibrosis patients, we believe its demonstrated biomarker activity across a broad spectrum of liver disease warrants continued evaluation in more advanced-stage NASH cirrhosis patients. We look forward to seeing the additional data readouts expected over the coming months and reviewing the totality of these results with our collaborators at Novartis to determine the most appropriate path forward.\u201d</li></ul><div class=\"tiny-share-widget\" data-id=\"3445040\" data-linked=\"Conatus Pharma&#39;s emricasan flunks mid-stage NASH study; shares down 54% premarket\" data-tweet=\"$CNAT - Conatus Pharma&#39;s emricasan flunks mid-stage NASH study; shares down 54% premarket https://seekingalpha.com/news/3445040-conatus-pharmas-emricasan-flunks-mid-stage-nash-study-shares-down-54-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3445040-conatus-pharmas-emricasan-flunks-mid-stage-nash-study-shares-down-54-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445039\" data-ts=\"1553256559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXLG\" target=\"_blank\">DXLG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445039-on-destination-xl-groups-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Destination XL Group&#39;s Q4 beat</a></h4><ul><li>Destination XL Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DXLG' title='Destination XL Group, Inc.'>DXLG</a>) reports comparable-store sales growth of 3.1% in <a href=\"https://seekingalpha.com/pr/17452523-destination-xl-group-inc-reports-fiscal-2018-fourth-quarter-full-year-financial-results\" target=\"_blank\">Q4</a>.</li><li>Gross margin rate fell 150 bps to 43.5%.</li><li>Merchandise margins down 160 bps Y/Y, primarily due to a shift in revenues from core private label to fashion and branded merchandise and the impact of wholesale segment.</li><li>SG&amp;A expense rate improved 300 bps to 38.3% .</li><li>Adjusted EBITDA grew 36% to $6.8M.</li><li>Inventories up 3.4% Y/Y to $106.8M.</li><li>Store count -10 Y/Y to 332.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445014-destination-xl-beats-0_04-beats-revenue\" target=\"_blank\">Destination XL beats by $0.04, beats on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445039\" data-linked=\"More on Destination XL Group&#39;s Q4 beat\" data-tweet=\"$DXLG - More on Destination XL Group&#39;s Q4 beat https://seekingalpha.com/news/3445039-on-destination-xl-groups-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3445039-on-destination-xl-groups-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445032\" data-ts=\"1553255792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMP\" target=\"_blank\">IMMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445032-immutep-nabs-patent-in-u-s-for-eftilagimod-alpha-in-cancer-shares-up-49-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immutep nabs patent in U.S. for eftilagimod alpha in cancer; shares up 49% premarket</a></h4><ul> <li>The USPTO has <a href=\"https://seekingalpha.com/pr/17452360-immutep-announces-united-states-patent-grant-eftilagimod-alpha-cancer\" target=\"_blank\">granted</a> a new patent, No, 10,232,038 to Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited'>IMMP</a>), entitled \u201cUse of Recombinant LAG-3 or the Derivatives thereof for Eliciting Monocyte Immune Response\u201d.</li>      <li>This new patent provides intellectual property protection for Immutep\u2019s method of treating cancer by the administration of a chemotherapy agent, and a plurality of doses of eftilagimod alpha (\u201cefti\u201d or \u201cIMP321\u201d) which is used to generate a monocyte mediated immune response.</li><li>The patent will expire on 3 October 2028.</li><li>Shares are up <font color=\"green\">49%</font> premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3445032\" data-linked=\"Immutep nabs patent in U.S. for eftilagimod alpha in cancer; shares up 49% premarket\" data-tweet=\"$IMMP - Immutep nabs patent in U.S. for eftilagimod alpha in cancer; shares up 49% premarket https://seekingalpha.com/news/3445032-immutep-nabs-patent-in-u-s-for-eftilagimod-alpha-in-cancer-shares-up-49-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3445032-immutep-nabs-patent-in-u-s-for-eftilagimod-alpha-in-cancer-shares-up-49-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445027\" data-ts=\"1553254913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445027-avonplus-6_8-on-sale-talks-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon +6.8% on sale talks report</a></h4><ul><li>Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) directors have discussed selling the company to Brazilian rival Natura &amp; Co, according to <a href=\"https://www.wsj.com/articles/avon-after-breakup-explores-deal-that-would-put-it-back-together-11553252401\" target=\"_blank\">WSJ sources</a>.</li><li>Talks are in early stages and include negotiations on where Natura would buy Avon's North American operations and the publicly-traded Avon operated elsewhere.</li><li>In September, the WSJ reported Natura had approached Avon about a potential takeover.</li><li>Avon shares are <font color=\"green\">up 6.8%</font> pre-market to $2.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445027\" data-linked=\"Avon +6.8% on sale talks report\" data-tweet=\"$AVP - Avon +6.8% on sale talks report https://seekingalpha.com/news/3445027-avonplus-6_8-on-sale-talks-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3445027-avonplus-6_8-on-sale-talks-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445026\" data-ts=\"1553254898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445026-greenbrierminus-3_5-after-issuing-below-consensus-q2-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier -3.5% after issuing below consensus Q2 earnings guidance</a></h4><ul><li>Greenbrier (NYSE:<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a>) <font color=\"red\">-3.5%</font> pre-market after providing a <a href=\"https://seekingalpha.com/pr/17452471-greenbrier-announces-new-railcar-orders-preliminary-results-fiscal-second-quarter\" target=\"_blank\">disappointing FQ2 outlook</a>, saying it expects to report EPS of $0.36-$0.38 vs. $0.42 analyst consensus estimate and $1.91 in the same period a year ago.</li><li>But GBX expects Q2 revenue of ~$650M, up from $629M in the year-ago quarter and well above $574M consensus.</li><li>GBX cites poor manufacturing execution in Romania compounded by supplier delivery failures and railcar contract loss contingencies, lower overhead absorption due to increased labor costs and lower railcar build activity at the Gunderson manufacturing, and continued challenges in railcar repair operations, including extreme winter weather and closure costs.</li><li>The company says it received orders for 3,800 new railcars with aggregate value of nearly $450M during the quarter, consistent with expectations; new railcar backlog totals 26K units valued at $2.7B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445026\" data-linked=\"Greenbrier -3.5% after issuing below consensus Q2 earnings guidance\" data-tweet=\"$GBX - Greenbrier -3.5% after issuing below consensus Q2 earnings guidance https://seekingalpha.com/news/3445026-greenbrierminus-3_5-after-issuing-below-consensus-q2-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3445026-greenbrierminus-3_5-after-issuing-below-consensus-q2-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445022\" data-ts=\"1553254075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445022-sorrentos-scilex-merges-semnur-pharma-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento&#39;s Scilex merges with Semnur Pharma; shares up 2% premarket</a></h4><ul><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) is up <font color=\"green\">2%</font> premarket on light volume in reaction to its <a href=\"https://seekingalpha.com/pr/17452521-sorrento-therapeutics-announces-merger-scilex-semnur-create-global-leader-non-opioid-pain\" target=\"_blank\">announcement </a>that subsidiary Scilex Pharmaceuticals has merged with Mountain View, CA-based <a href=\"http://www.semnurpharma.com/#modal-promo\" target=\"_blank\">Semnur Pharmaceuticals</a>. The combined company will do business as Scilex Holding Company.</li><li>Sorrento's 77% in Scilex Pharma will translate into 58% stake in Scilex Holding. Lead commercial product will be ZTlido (lidocaine topical system 1.8%), approved by the FDA last month for the relief of pain associated with post-herpetic neuralgia (post-shingles pain). Lead pipeline candidate will be Semnur's <a href=\"http://www.semnurpharma.com/clinical-study/\" target=\"_blank\">SP102</a>, a non-opioid corticosteroid gel, in Phase 3 development for the treatment of lumbar radicular pain/sciatica, a Fast Track indication in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3445022\" data-linked=\"Sorrento&#39;s Scilex merges with Semnur Pharma; shares up 2% premarket\" data-tweet=\"$SRNE - Sorrento&#39;s Scilex merges with Semnur Pharma; shares up 2% premarket https://seekingalpha.com/news/3445022-sorrentos-scilex-merges-semnur-pharma-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3445022-sorrentos-scilex-merges-semnur-pharma-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445018\" data-ts=\"1553253335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445018-tiffany-down-4-on-mixed-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiffany down 4% on mixed Q4 results</a></h4><ul><li>Tiffany (NYSE:<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>) reports comparable-store sales declined 1% in <a href=\"https://seekingalpha.com/pr/17452489-tiffany-reports-net-sales-net-earnings-growth-full-year-2018-management-reiterates\" target=\"_blank\">Q4</a>.</li><li>Geographic revenue: Americas: $618M (flat); Asia-Pacific: $316M (-1%); Japan: $196M (+3%); Europe: $162M (-3%); Other: $29M (-25%).</li><li>Gross margin rate -10 bps to 63.8%.</li><li>Operating margin rate dropped 300 bps to 20.3%.</li><li>Inventory increased 8% Y/Y to $2.43B.</li><li>Store count +6 Y/Y to 321.</li><li><b>FY2019 Guidance</b>: Net sales: increase by a low-single-digit percentage; Comparable sales: Low-single-digit growth; Operating margin rate: slightly above Y/Y; Tax rate: ~23%; Diluted EPS: increase by a mid-single-digit percentage; Free cash flow: at least $400M; Capex: $350M.</li><li>TIF <font color=\"red\">-4.06%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445010-tiffany-beats-0_07-misses-revenue\" target=\"_blank\">Tiffany beats by $0.07, misses on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445018\" data-linked=\"Tiffany down 4% on mixed Q4 results\" data-tweet=\"$TIF - Tiffany down 4% on mixed Q4 results https://seekingalpha.com/news/3445018-tiffany-down-4-on-mixed-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3445018-tiffany-down-4-on-mixed-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3445011\" data-ts=\"1553251655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIBB\" target=\"_blank\">HIBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3445011-hibbett-sports-beat-estimates-in-q4-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hibbett Sports beat estimates in Q4, shares down 2% premarket.</a></h4><ul><li>Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>) reports comparable-store sales rose 3.8% in <a href=\"https://seekingalpha.com/pr/17452483-hibbett-reports-fourth-quarter-fiscal-2019-results\" target=\"_blank\">Q4</a>.</li><li>E-commerce sales comprised of 10.6% of total sales.</li><li>Gross margin rate decreased 40 bps to 31.1%.</li><li>Store operating, selling, and administrative expenses rate up 230 bps to 25.5%.</li><li>Store count +84 Y/Y to 1,163.</li><li>During the quarter, company repurchased 3,900 shares of common stock for $0.1M.</li><li>The company expects to open ~10 to 15 new store with approximately 95 store closures in FY2020.</li><li><b>FY2020 Guidance</b>: Comparable-store sales: -1% to +1%; Adjusted gross margin: +35 bps to +55 bps; SG&amp;A expense: +15 bps to +25 bps; Diluted EPS: $1.50 to $1.70; Adjusted EPS: $1.80 to $2; Tax rate: ~24.5%; Capex: ~18M to $22M; Share buyback: ~$10M to $15M.</li><li>HIBB <font color=\"red\">-1.77%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3445007-hibbett-sports-beats-0_18-beats-revenue\" target=\"_blank\">Hibbett Sports beats by $0.18, beats on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3445011\" data-linked=\"Hibbett Sports beat estimates in Q4, shares down 2% premarket.\" data-tweet=\"$HIBB - Hibbett Sports beat estimates in Q4, shares down 2% premarket. https://seekingalpha.com/news/3445011-hibbett-sports-beat-estimates-in-q4-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3445011-hibbett-sports-beat-estimates-in-q4-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 AM </div></div></li>","count":60,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}